DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...

DexCom, Inc. (NASDAQ:DXCM), founded in 1999 ... DXCM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Globus Medical (GMED – Research Report), with a ...

U.S. equities rose at midday as investors awaited word from the Federal Reserve about the future of interest rates.

The Port of San Diego wants to demolish the 77-year-old police headquarters on East Harbor Island and erect a new facility at ...

The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching ...